Mood Disorders: Clinical Trials

6,145 trials for Mood Disorders, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3696 completed, 736 unknown, 706 recruiting, 359 terminated. 2666 Not applicable, 821 Phase 2, 753 Phase 3, 648 Phase 4, 391 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable2666Completed 1431, Recruiting 404, Unknown 395, Not yet recruiting 134, Terminated 109, Active not recruiting 89, Withdrawn 61, Enrolling by invitation 28, Suspended 15
Phase 2821Completed 529, Recruiting 84, Terminated 76, Unknown 55, Withdrawn 33, Active not recruiting 20, Not yet recruiting 20, Enrolling by invitation 2, Suspended 2
Phase 3753Completed 559, Terminated 67, Recruiting 47, Unknown 28, Withdrawn 25, Active not recruiting 15, Not yet recruiting 9, Suspended 2, Enrolling by invitation 1
Phase 4648Completed 437, Unknown 73, Terminated 56, Recruiting 30, Withdrawn 30, Not yet recruiting 15, Active not recruiting 5, Enrolling by invitation 1, Suspended 1
Phase 1391Completed 280, Recruiting 26, Terminated 26, Unknown 24, Withdrawn 18, Not yet recruiting 8, Active not recruiting 6, Enrolling by invitation 2, Suspended 1
Early Phase 151Completed 20, Unknown 13, Recruiting 7, Terminated 4, Withdrawn 3, Active not recruiting 2, Enrolling by invitation 1, Not yet recruiting 1

Follow Mood Disorders: new trials by email Literature Review of Mood Disorders trials Research Report on Mood Disorders

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Personalized Pharmaco-Lifestyle Interventions for Severe Mental Illnesses (LIFETRAIN)
Semaglutide (SEMA), Exercise module, Anti-inflammatory diet module - Severe Mental Illness, Depression / Major Depressive Disorder
Not applicableNot yet recruitingLudwig-Maximilians - University of Munich1402028-10-012026-05-14
Whole-Body Hyperthermia for Mood and Anxiety Disorders
Whole-Body Hyperthermia, fMRI - Postpartum Depression, Mood Disorders
Not applicableNot yet recruitingWeill Medical College of Cornell University2402028-06-012026-06-23
ACT for Veterans With IBD and Mental Health Challenges
Acceptance and Commitment Therapy - Inflammatory Bowel Diseases, Crohn's Disease
Not applicableNot yet recruitingVA Office of Research and Development502028-01-012026-02-09
iMORE+ Study: A Multi-Omics Cohort Study of Major Depressive Disorder
Major Depressive Disorder (MDD)
Not yet recruitingShanghai Mental Health Center1502027-09-012026-08-03
Efficacy and Safety of Bupropion Hydrobromide in Adolescents and Children With Major Depressive Disorder
bupropion hydrobromide, Placebo - Major Depressive Disorder
Phase 4Not yet recruitingBausch Health Americas, Inc.2462027-07-012026-09-29
Evaluation of the Acceptability, Feasibility and Exploration of the Efficacy of an Integrated Care Pathway CARIBOU
CARIBOU Integrated Care Pathway, Treatment as Usual (TAU) - Major Depressive Disorder (MDD)
Not applicableNot yet recruitingUniversidad de los Andes, Chile722027-07-012026-10-20
Targeted Alternating Current and Cognitive Training Intervention for Cognitive Control in Bipolar Disorders
Soterix 1x1 tES mini-CT - Bipolar Disorder, Bipolar and Related Disorders
Not applicableNot yet recruitingVA Office of Research and Development1382027-06-012026-09-28
Stony Brook Medicine Anti-Inflammatory Trial
Celecoxib, Minocycline - Major Depressive Disorder
Phase 4Not yet recruitingStony Brook University422027-06-012026-04-23
CYOA App Intervention for Social Media Use in Adolescents With Depression
Choose Your Own Adventure App - Major Depressive Disorder, Depression
Not applicableNot yet recruitingUniversity of Minnesota602027-06-012026-11-13
Efficacy of a Personalized, Response-based Transdiagnostic Intervention for Emotional Disorders Delivered Via the Internet: A Protocol for an Adaptive Randomized Controlled Trial
UJI Online Transdiagnostic Protocol, UJI On Line Transdiagnostic Hibrid Protocol - Emotional Disorders, Anxiety
Not applicableNot yet recruitingUniversitat Jaume I3662027-05-012026-05-27
A Mobile Health Intervention to Improve Psychosocial Functioning in Veterans With Posttraumatic Stress Disorder and Depression Symptoms
Self-Guided STAIR Coach with Real-Time Assessment, Real-Time Assessment - Psychosocial Functioning, Stress Disorders, Post-Traumatic
Not applicableNot yet recruitingVA Office of Research and Development402027-04-012026-10-06
Role of Kynurenine Pathway and Its Metabolites in Depressive Disorders, Major Depressive Disorder is Suspected to Have the Greatest Burden by 2030,Kynurenine Pathway is Major Route Through Which the Essential Amino Acid Tryptophan is Metabolised and Activated in Time of Stress and Immune Activation.
Major Depressive Disorder (MDD)
Not yet recruitingSohag University902027-03-142026-08-20
Psilocybin Assisted Psychotherapy for Treatment Resistant Depression and Co-occurring Substance Use Disorder
Psilocybin - Treatment Resistant Depression, Substance Use Disorders
Phase 1 / Phase 2Not yet recruitingIndiana University502027-02-012026-10-23
Sleep Monitoring for Early Detection of Relapse in People With Schizophrenia or Bipolar Disorder Receiving Usual Treatment
Bipolar Disorder (BD), SCHIZOPHRENIA 1 (Disorder)
Not yet recruitingInternational University of La Rioja302027-02-012026-11-06
A Phase I/II Study of PDC-1421 for Treating Depression in Cancer Patients
PDC-1421 Capsule - Major Depressive Disorder
Phase 1 / Phase 2Not yet recruitingBioLite, Inc.122027-01-152026-04-20
Electrical Vestibular Nerve Stimulation (VeNS) as a Treatment for Major Depressive Disorder (MDD)
Active VeNS Device, Sham VeNS Device - Major Depressive Disorder \(MDD, Depressive Disorder, Major
Not applicableWithdrawnNeurovalens Ltd.2027-01-062026-11-18
Psilocybin for Depression in Veterans
Psilocybin, modafinil, zolpidem - Major Depression
Phase 2Not yet recruitingVA Office of Research and Development1502027-01-012026-10-26
Effect of Neurofeedback and TMS
Repetitive Transcranial Magnetic Stimulation, Alpha-down EEG Neurofeedback - Depression - Major Depressive Disorder
Not applicableNot yet recruitingMassachusetts General Hospital202027-01-012026-10-23
Qualitative Study of Student Financial Insecurity and Psychiatry
Semi-structured interviews - Depressive Disorder, Generalized Anxiety Disorder
Not yet recruitingAssistance Publique - Hôpitaux de Paris302027-01-012026-08-05
Brain Network Mechanisms of Cognitive Impairments in Major Psychiatric Disorders and Their Clinical Applications
repetitive transcranial magnetic stimulation (rTMS) - Schizophrenia, Bipolar Disorder
Not applicableNot yet recruitingCentral South University4002027-01-012026-03-04

Showing 20 of 6145. Sign in to see all of them.

Narrower conditions

Depressive Disorder, Major (2987)  ·  Depression (1790)  ·  Bipolar Disorder (1672)  ·  Depressive Disorder (856)  ·  Depression, Postpartum (566)  ·  Anxiety Disorders (515)  ·  Depressive Disorder, Treatment-Resistant (449)  ·  Schizophrenia (425)  ·  Psychotic Disorders (278)  ·  Mental Disorders (237)  ·  Stress Disorders, Post-Traumatic (158)  ·  Psychological Well-Being (123)  ·  Mania (119)  ·  Suicidal Ideation (102)

Broader conditions

Mental Disorders (5908)  ·  Depressive Disorder (3656)  ·  Behavior (2194)  ·  Behavioral Symptoms (1888)  ·  Bipolar and Related Disorders (1663)  ·  Pathological Conditions, Signs and Symptoms (670)  ·  Urogenital Diseases (613)  ·  Female Urogenital Diseases and Pregnancy Complications (597)  ·  Pregnancy Complications (561)  ·  Puerperal Disorders (554)  ·  Nervous System Diseases (524)  ·  Schizophrenia Spectrum and Other Psychotic Disorders (517)  ·  Signs and Symptoms (460)  ·  Neurologic Manifestations (346)

Interventions

Escitalopram (201)  ·  Ketamine (165)  ·  Transcranial Magnetic Stimulation (164)  ·  Therapeutics (133)  ·  Cognitive Behavioral Therapy (121)  ·  Sertraline (115)  ·  Quetiapine Fumarate (104)  ·  Duloxetine Hydrochloride (102)  ·  Fluoxetine (88)  ·  Transcranial Direct Current Stimulation (81)  ·  Aripiprazole (80)  ·  Lithium (80)  ·  Vortioxetine (71)  ·  Bupropion (67)  ·  Venlafaxine Hydrochloride (63)

Sponsors

Massachusetts General Hospital (160)  ·  National Institute of Mental Health (NIMH) (121)  ·  GlaxoSmithKline (86)  ·  New York State Psychiatric Institute (83)  ·  Stanford University (83)  ·  Eli Lilly and Company (80)  ·  AstraZeneca (77)  ·  Centre for Addiction and Mental Health (77)  ·  Mclean Hospital (67)  ·  Shanghai Mental Health Center (60)  ·  University of Pittsburgh (59)  ·  VA Office of Research and Development (57)  ·  Janssen Research & Development, LLC (54)  ·  Otsuka Pharmaceutical Development & Commercialization, Inc. (50)  ·  University of Texas Southwestern Medical Center (50)

Countries

United States (2838)  ·  Canada (547)  ·  China (346)  ·  France (305)  ·  Germany (280)  ·  United Kingdom (198)  ·  Spain (195)  ·  Turkey (Türkiye) (147)  ·  Poland (126)  ·  Taiwan (115)  ·  Denmark (114)  ·  Australia (107)  ·  Brazil (106)  ·  South Korea (105)  ·  Sweden (101)

Top investigators

Carlos A Zarate, M.D. (15)  ·  Maurizio Fava, MD (15)  ·  Martha Sajatovic, MD (12)  ·  Hesheng Liu, Ph.D. (11)

Results publications

PMID 34817851, PMID 34510411, PMID 25758058, PMID 39428602, PMID 26644956, PMID 26709542, PMID 34183490, PMID 42383885, PMID 24816198, PMID 29140227, PMID 34131914, PMID 24067192, PMID 24175720, PMID 24571916, PMID 26474010, PMID 29912955, PMID 30508090, PMID 22700038, PMID 27685842, PMID 27780334, PMID 31577867, PMID 31818787, PMID 32792252, PMID 33128208, PMID 34523118, PMID 36708956, PMID 41401709, PMID 17074942, PMID 23485955, PMID 23497790, PMID 26644957, PMID 27488181, PMID 29608461, PMID 31969269, PMID 32242018, PMID 32476658, PMID 32860422, PMID 34235612, PMID 34286512, PMID 34689733, PMID 34874888, PMID 37656180, PMID 38819882, PMID 41130742, PMID 42393474, PMID 11556941, PMID 16390886, PMID 21095016, PMID 21731833, PMID 22106941

NIH funding

2023 (18), 2008 (15), 2025 (15), 2016 (14), 2018 (12), 2019 (12), 2014 (11), 2015 (9), 2017 (8), 2004 (3), 2009 (3), R25DA020537 (3), 2005 (2), 271201100006I-0-27100007-1 (2), 5UH3NS103550 (2)